Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 192,106 | 59,050 | 70,331 | 83,374 | 96,661 |
| TOTAL | $197,482 | $60,839 | $71,526 | $84,552 | $98,172 |
| Non-Current Assets | |||||
| PPE Net | 519 | 618 | 720 | 821 | 925 |
| Other Non-Current Assets | 693 | 660 | 589 | 697 | 785 |
| TOTAL | $1,212 | $1,278 | $1,309 | $1,518 | $1,710 |
| Total Assets | $198,694 | $62,117 | $72,835 | $86,070 | $99,882 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,022 | 1,433 | 1,290 | 2,381 | 2,344 |
| Accrued Expenses | 2,898 | 3,939 | 4,390 | 4,660 | 5,895 |
| TOTAL | $14,329 | $5,921 | $6,247 | $7,597 | $8,785 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12 | 12 | 160 | 307 | 449 |
| TOTAL | $12 | $12 | $160 | $307 | $449 |
| Total Liabilities | $14,341 | $5,933 | $6,407 | $7,904 | $9,234 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,395 | 13,674 | 13,548 | 13,530 | 13,510 |
| Common Shares | 4 | 1 | 1 | 1 | 1 |
| Retained earnings | -229,398 | -214,241 | -200,738 | -186,039 | -170,649 |
| TOTAL | $184,353 | $56,184 | $66,428 | $78,166 | $90,648 |
| Total Liabilities And Equity | $198,694 | $62,117 | $72,835 | $86,070 | $99,882 |